We serve 2′,3′,5′-Tri-O-acetyluridine CAS:13189-00-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White or almost white crystalline powder | Conform |
| Loss on drying | ≤1.0% | 0.02% |
| Residue on ignition | ≤0.2% | 0.06% |
| Heavy Metals | ≤20 ppm | Conform |
| Purity | ≥98% | 99.0% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like 2′,3′,5′-Tri-O-acetyluridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′,3′,5′-O-triacetyluridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TAU Use and application,Tri-O-acetyl uridine technical grade,usp/ep/jp grade.
Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.6-amino-9-(O3,O5-hydroxyphosphoryl-β-D-arabinofuranosyl)-7,9-dihydro-purine-8-thione manufacturer Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.2-(4-chloro-phenyl)-4-hexyl-2,4-dihydro-[1,2,4]triazol-3-one supplier The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. 2-tosylethyl (E)-3-(2-(3-(2-bromoacetoxy)butyl)-1,3-dithian-2-yl)acrylate vendor The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.
